Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    FP07 - Pathology

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Type: Posters (Featured)
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      FP07.06 - Lung Immune Prognostic Index (LIPI) in Advanced NSCLC Patients Treated with Immunotherapy, Chemotherapy and both Combined Upfront.

      00:00 - 00:00  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

    • +

      FP07.11 - Circulating Tumor DNA (ctDNA) Clearance as a Biomarker in Patients With Locally Advanced NSCLC Following Chemoradiation

      00:00 - 00:00  |  Presenter: Brendan James Knapp

      • Abstract

      Loading...

  • +

    P09 - Health Services Research/Health Economics - Real World Outcomes

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Health Services Research/Health Economics
    • +

      P09.15 - Severity of Lung Cancer Disease in Hospitalized Patients During COVID-19

      00:00 - 00:00  |  Presenter: Laia Fernández-Mañas

      • Abstract

      Loading...

    • +

      P09.28 - Access to Intermediate and Intensive Care for Patients With Lung Cancer During the COVID-19 Period

      00:00 - 00:00  |  Presenter: Teresa Gorría

      • Abstract

      Loading...

  • +

    P33 - Pathology - Immunotherapy Biomarker

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P33.10 - Identification of Long-Responders and Fast-Progressors under Immunotherapy Based on Early Monitoring of dNLR in Advanced NSCLC Patients

      00:00 - 00:00  |  Presenter: Mariona Riudavets

      • Abstract

      Loading...

  • +

    P34 - Pathology - Liquid Biopsy

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      P34.06 - The Clinical Utility of Liquid Biopsy by Digital Droplet PCR in Patients with Advanced NSCLC

      00:00 - 00:00  |  Presenter: Virginie Jeanine Lamberts

      • Abstract

      Loading...

  • +

    P84 - Targeted Therapy - Clinically Focused - ALK

    • 00:00 - 00:00
    • 1/28/2021
    • Location: ePoster Hall
    • Not for CME Credit
    • Type: Posters
    • Track: Targeted Therapy - Clinically Focused
    • +

      P84.01 - The ARIA Study: Activity of Next-Generation ALK TKIs Based on ALK Resistance Mutations Detected by Liquid Biopsy in ALK Positive NSCLC Patients.

      00:00 - 00:00  |  Presenter: Laura Mezquita

      • Abstract

      Loading...

  • +

    MA03 - New and Revisited Prognostic Factors in Early Stage Lung Cancer

    • 15:30 - 16:30
    • 1/29/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Early Stage/Localized Disease
    • +

      MA03.08 - Impact of COVID-19 Pandemic in the Diagnosis and Prognosis of Lung Cancer

      15:55 - 16:00  |  Presenter: Roxana Reyes

      • Abstract

      Loading...

  • +

    OA07 - Immuno-biology and Novel Immunotherapeutics from Bench to Bed

    • 10:30 - 11:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Immuno-biology and Novel Immunotherapeutics (Phase I and Translational)
    • +

      OA07.10 - Discussant

      11:15 - 11:20  |  Presenter: Laura Mezquita

      • Abstract

      No abstract available for this presentation

  • +

    MA08 - Advances in Biomarkers for Immune Checkpoint Blockade and Targeted Therapy in Non Small Cell Lung Carcinoma

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      MA08.04 - LIPI and Outcomes of Durvalumab as Consolidation Therapy after ChRT in Patients with Locally-Advanced NSCLC

      16:50 - 16:55  |  Presenter: Mariona Riudavets

      • Abstract

      Loading...